Revitalist Publishes Proprietary Diagnostic Tool After Receiving Certificate of Registration from The United States… Jan 27, 2022
COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360… Dec 1, 2021
Non-Hallucinogenic Psilocybin & Mental Health: Diamond Therapeutics’ Historic Clinical Trial Begins Nov 24, 2021
MindMed Announces Financial Results for the Third Quarter 2021 and Business Highlights; Cash Balance of $145.9 USD… Nov 15, 2021
